Bank Of Nova Scotia Astrazeneca PLC Transaction History

Bank Of Nova Scotia

  • $56.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$54.21 - $70.44 $83,483 - $108,477
-1,540 Reduced 31.65%
3,326 $225,000
Q3 2022

Nov 10, 2022
SELL
$53.02 - $135.75 $26,244 - $67,196
-495 Reduced 9.23%
4,866 $267,000
Q2 2022

Aug 05, 2022
BUY
$59.26 - $71.14 $317,692 - $381,381
5,361 New
5,361 $355,000

Others Institutions Holding AZN

# of Institutions
1,343
Shares Held
492M
Call Options Held
4.99M
Put Options Held
3.19M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email